Physician profile
Alice Lynn Risner
NPI 1164984746
$344.26
in general payments reported to CMS, 2019-2025
12 companies · $324 in 2025
The $324 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $19.98 · 2025: $324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $324 · Long Term Medical Supply Or Device Loan: $19.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $324.28 |
| Long Term Medical Supply Or Device Loan | $19.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $64.34 | 2025 | Zepbound, Mounjaro, Jardiance |
| Abbvie INC. | $49.66 | 2025 | |
| Abbott Laboratories | $36.47 | 2024-2025 | Freestyle Insulinx, Freestyle Libre 3 |
| Phathom Pharmaceuticals, INC. | $35.62 | 2025 | Voquezna |
| Actelion Pharmaceuticals US, INC. | $24.32 | 2025 | Uptravi, Opsumit |
| Seqirus USA INC | $22.68 | 2025 | Fluad, Flucelvax |
| Axsome Therapeutics, INC. | $21.66 | 2025 | Auvelity |
| Pfizer INC. | $20.10 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.41 | 2025 | |
| Novo Nordisk INC | $19.14 | 2025 | Wegovy |
| Amgen INC. | $16.00 | 2025 | Evenity |
| Exact Sciences Corporation | $14.86 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alice Risner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.